|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
15.89 Billion
|
|
Market
Size (2030)
|
USD
22.14 Billion
|
|
CAGR
(2025-2030)
|
5.68%
|
|
Fastest
Growing Segment
|
Chronic
Kidney Disease
|
|
Largest
Market
|
North
America
|
Market Overview
Global Oral
Clinical Nutrition Market was valued at USD 15.89 billion in 2024 and is
expected to reach USD 22.14 billion by 2030 with a CAGR of 5.68% during the
forecast period. Global Oral Clinical Nutrition Market is poised to grow at an
impressive rate during the forecast period on account of rising incidence of
chronic diseases, and an increasing focus on patient-centric care. In addition,
the growing prevalence of malnutrition and related conditions such as
sarcopenia and cachexia are also fueling demand for the products.
Increasing
demand for products that provide essential nutrients to patients who are unable
to consume adequate amounts of food through normal means. This market
encompasses a wide range of products, including supplements, enteral feeding
formulas, and medical foods, all designed to provide patients with the
nutrients they need to support their recovery and maintain their health.
Key Market Drivers
Increasing Geriatric
Population and Associated Malnutrition Risks
One
of the primary drivers for the global oral clinical nutrition market is the
rising aging population, which is closely associated with higher risks of
malnutrition and chronic illnesses. As people age, they often experience a
natural decline in appetite, digestive efficiency, and overall nutritional
intake. This can lead to malnutrition, weight loss, muscle wasting, and a
compromised immune system. Oral clinical nutrition products play a crucial role
in addressing these deficiencies by providing concentrated forms of essential
nutrients, proteins, vitamins, and minerals in palatable and easily digestible
forms.
Globally, the
aging population is growing rapidly. According to WHO, by 2030, 1 in 6
people in the world will be aged 60 years or over. At this time the share of
the population aged 60 years and over will increase from 1 billion in 2020 to
1.4 billion. By 2050, the world’s population of people aged 60 years and older
will double (2.1 billion). The number of people aged 80 years or older is
expected to triple between 2020 and 2050 to reach 426 million. Many
governments are increasingly emphasizing senior healthcare services and
home-based nutritional support programs. For example, several countries in
Europe and Asia have implemented national nutrition guidelines and funded
nutrition supplementation programs targeting older adults. These initiatives
increase the visibility and accessibility of oral clinical nutrition products.
Furthermore,
hospitals, nursing homes, and long-term care facilities are also prioritizing
nutritional interventions, especially post-surgery or during recovery from
illness, which boosts the demand. With the elderly population expected to
continue expanding in the coming decades, the demand for oral clinical
nutrition is expected to rise substantially as a preventive and therapeutic
healthcare strategy.
Rising Prevalence of Chronic
Diseases and Recovery Nutrition
Another
significant factor propelling the market is the increasing prevalence of
chronic conditions such as cancer, diabetes, gastrointestinal disorders, and renal
diseases. Patients with these conditions often require enhanced nutritional
support to manage symptoms, recover post-treatment, and maintain their overall
health. Oral clinical nutrition serves as a key therapeutic adjunct in managing
the nutritional status of patients undergoing chemotherapy, dialysis, or
surgery. According to WHO, Noncommunicable diseases (NCDs) killed at least
43 million people in 2021, equivalent to 75% of non-pandemic-related deaths
globally.
In
2021, 18 million people died from an NCD before age 70 years; 82% of these
premature deaths occur in low- and middle-income countries. Of all NCD deaths,
73% are in low- and middle-income countries. Cardiovascular diseases account
for most NCD deaths, or at least 19 million deaths in 2021, followed by cancers
(10 million), chronic respiratory diseases (4 million), and diabetes (over 2
million including kidney disease deaths caused by diabetes).
Healthcare
providers are placing more emphasis on nutritional interventions as part of
holistic treatment plans, especially as studies continue to show improved
clinical outcomes when patients receive adequate nutrition. Malnutrition among
hospitalized patients remains a global concern, often resulting in longer
hospital stays and increased healthcare costs. Therefore, nutrition-focused
care, particularly through oral clinical supplements, is becoming a cornerstone
of clinical protocols in both inpatient and outpatient settings.
Government
health systems are beginning to acknowledge the role of nutrition in chronic
disease management and recovery. Policies supporting hospital nutrition
programs, reimbursement for nutritional products, and integration of dietitians
into clinical teams are boosting the growth of this market. As chronic diseases
remain a global health burden, the demand for effective, easy-to-administer
nutritional support continues to grow.
Download Free Sample Report
Key Market Challenges
High Cost and Limited
Reimbursement in Developing Regions
One
of the major challenges hindering the growth of the global oral clinical
nutrition market is the relatively high cost of specialized nutritional
products, especially in low- and middle-income countries. While these
supplements are critical in preventing malnutrition and supporting recovery,
their affordability remains a barrier for many patients, particularly in
regions with underfunded healthcare systems.
In
several countries, oral clinical nutrition products are not covered under
national health insurance schemes or public reimbursement programs. This places
the financial burden on patients and their families, often leading to
suboptimal nutritional support. The lack of inclusion in essential medicine
lists or government procurement plans further limits accessibility, especially
in rural and underserved areas.
Additionally,
the cost of manufacturing high-quality, disease-specific formulations
contributes to higher retail prices. This creates a disparity between developed
and developing markets, where adoption is significantly lower due to economic
constraints. Although some NGOs and public health organizations have launched
nutrition assistance programs, widespread access remains limited.
To
overcome this challenge, collaboration between governments, manufacturers, and
public health bodies is essential. Initiatives aimed at subsidizing costs,
expanding reimbursement coverage, and promoting local production of
cost-effective clinical nutrition products could improve accessibility and
drive market growth in developing regions.
Regulatory and Labelling
Complexities
Navigating
the regulatory landscape for oral clinical nutrition products remains a
substantial challenge for manufacturers. These products often fall in a gray
area between dietary supplements and pharmaceutical interventions, leading to
ambiguity in classification, safety standards, and labelling requirements.
Regulatory frameworks vary significantly between countries and even within
regions, complicating global product launches and distribution.
For
example, in some countries, clinical nutrition products must undergo stringent
approval processes like drug trials, including clinical efficacy data and
safety assessments. In contrast, other markets classify them as food
supplements, requiring only basic quality assurance. This lack of harmonization
affects product timelines, costs, and the ability to market products
effectively.
Labelling
standards are further complicated matters. Guidelines for nutrient content
claims, health claims, and usage instructions vary widely, requiring companies
to create multiple product versions to comply with local regulations. Missteps
in labelling can result in penalties, product recalls, or bans, impacting brand
reputation.
Moreover,
increasing scrutiny by regulatory bodies and rising consumer expectations
around transparency and evidence-based claims are prompting stricter compliance
requirements. As a result, companies must invest heavily in regulatory
expertise and legal advisory services to ensure adherence, which may restrict
the entry of small and medium players into the market.
Key Market Trends
Personalization in Clinical
Nutrition Formulations
Personalization
is emerging as a transformative trend in oral clinical nutrition, with
manufacturers developing specialized products tailored to individual needs.
This shift is driven by the recognition that nutritional requirements vary
significantly across patient demographics, disease states, age groups, and
genetic profiles. Personalized nutrition allows for more targeted treatment
plans, improving patient adherence and outcomes.
Technological
advances, particularly in nutrigenomics and digital health monitoring, are
enabling healthcare providers to better assess patients’ metabolic profiles and
nutritional deficiencies. These insights allow for customized formulations that
address specific deficiencies or therapeutic goals, whether it’s boosting
immunity, improving muscle mass, or aiding recovery from gastrointestinal
issues.
Furthermore,
there's a growing demand for disease-specific nutrition, such as products for
oncology patients, diabetic individuals, and those with kidney or liver
dysfunction. As consumers become more health-conscious and involved in their
care, the market is witnessing a shift from generic products to those that
promise targeted benefits.
Governments
and healthcare institutions are also promoting research into personalized
nutrition through grants and partnerships, which could accelerate innovation in
this space. As awareness grows and technologies become more accessible,
personalized oral clinical nutrition is likely to redefine product development
strategies within industry.
Growing Integration of Oral
Clinical Nutrition in Home Healthcare
The
trend of incorporating oral clinical nutrition products into home healthcare
settings is gaining momentum. Factors such as the aging population, rising
healthcare costs, and patient preferences for in-home care are driving the
adoption of home-based medical nutrition. Home healthcare enables patients
recovering from surgery, managing chronic conditions, or undergoing long-term
treatment to maintain nutritional intake without the need for hospital visits.
This
shift has been facilitated by improvements in product packaging, shelf
stability, and ease of use. Many oral clinical nutrition supplements are now
available in ready-to-drink or powder formats, making them convenient for home
administration by caregivers or patients themselves. Additionally, health and
digital health platforms are enabling regular nutritional consultations and
follow-ups, ensuring patients receive continuous care.
The
COVID-19 pandemic further accelerated this trend, highlighting the need for
decentralized healthcare solutions. Governments and health systems have
responded by promoting community-based care, home nutrition programs, and
subsidies for in-home nutritional products. As healthcare continues to shift
towards more patient-centric and cost-effective models, home-based oral
clinical nutrition will become an integral part of chronic disease management
and recovery plans.
Segmental Insights
Indication Insights
Based
on Indication, the cancer care segment accounted for the largest share in 2024.
This prominence can be attributed to several factors, including the rising
prevalence of cancer driven by unhealthy lifestyles, environmental factors,
poor dietary habits, genetic predispositions, and weakened immune systems. As
cancer rates continue to climb globally, the demand for early diagnosis and
treatment has led to the widespread adoption of advanced therapies such as
chemotherapy and radiation. While these treatments are essential in managing
cancer, they often come with severe side effects that negatively impact
patients' nutritional intake, leading to weight loss, malnutrition, and overall
declines in physical health.
To
address these nutritional challenges, the need for specialized oral clinical
nutrition products has grown significantly within the cancer care segment.
These products are designed to help patients maintain adequate nutrient levels,
support recovery, and improve treatment outcomes by counteracting the effects
of reduced appetite and impaired digestion caused by cancer therapies. For
example, in April 2020, Esperer Onco Nutrition introduced oral clinical
nutrition supplements such as Es-Fortitude and Es-Invigour. These products
are formulated specifically for cancer patients experiencing weight loss due to
chemotherapy and other treatments, providing essential nutrients in an easily
consumable form to help manage malnutrition during treatment.
Download Free Sample Report
Regional Insights
Based
on the region, North America held the largest market share in the global oral
clinical nutrition market, owing to a combination of advanced healthcare
infrastructure, high awareness of clinical nutrition, and strong presence of
leading market players. The region benefits from well-established hospital
networks, home healthcare services, and long-term care facilities that
routinely incorporate oral clinical nutrition into patient care protocols.
Additionally, North America has seen increasing demand for nutrition management
among aging populations, individuals with chronic diseases, and patients
recovering from surgeries or undergoing cancer treatments. Healthcare providers
in North America are more inclined to adopt evidence-based nutritional therapy
as a standard component of medical treatment, largely due to the growing
recognition of the role nutrition plays in recovery and disease prevention.
Furthermore, high consumer awareness, better affordability, and favorable
reimbursement policies across many U.S. states and Canadian provinces
contribute to widespread adoption of oral nutritional supplements in both
hospital and outpatient settings.
Recent Developments
In
October 2023, Nutricia, part of Danone, launched its first medical nutrition
drink, Fortini + Mix Multi Fibre, formulated to manage disease-related
malnutrition and faltering growth in pediatric patients. The drink is ready to
drink and provides 1/3 of the recommended daily intake of fruits and
vegetables. Co-created with parents and younger patients, Fortini + Mix Multi
Fibre is an innovative product within the Fortini pediatric feed range. The
launch builds on Nutricia's expertise in medical nutrition solutions,
supporting children with various medical conditions to grow and develop
optimally.
Key Market Players
- Abbott Laboratories,
Inc.
- Pfizer, Inc.
- Bayer AG
- Nestle SA
- GlaxoSmithKline plc
- Baxter
International Inc.
- Otsuka Holdings,
Co. Ltd.
- Baxter
International Inc.
- Victus, Inc.
- Danone SA(Nutricia)
|
By Indication
|
By Distribution Channel
|
By Region
|
- Alzheimer’s
- Nutritional
Deficiencies
- Cancer
Care
- Chronic
Kidney Disease
- Dysphagia
- Others
|
- Direct
Sales
- Indirect
Sales
|
- North
America
- Europe
- Asia-Pacific
- South
America
- Middle
East & Africa
|
Report Scope:
In this report, the Global Oral Clinical Nutrition
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- Oral Clinical Nutrition Market, By Indication:
o Alzheimer’s
o Nutritional Deficiencies
o Cancer Care
o Chronic Kidney Disease
o Dysphagia
o Others
- Oral Clinical Nutrition Market, By Distribution Channel:
o Direct Sales
o Indirect Sales
- Oral Clinical Nutrition Market, By Region:
o North America
§ United States
§ Mexico
§ Canada
o Europe
§ France
§ Germany
§ United Kingdom
§ Italy
§ Spain
o Asia-Pacific
§ China
§ India
§ South Korea
§ Japan
§ Australia
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East and Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Oral
Clinical Nutrition Market.
Available Customizations:
Global Oral Clinical Nutrition Market report
with the given market data, TechSci Research offers customizations according to
a company's specific needs. The following customization options are available
for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Oral Clinical Nutrition Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at sales@techsciresearch.com